HIGH-THROUGHPUT DRUG TARGET IDENTIFICATION WITH THE EVOSEP ONE
The Evosep One is specifically designed for clinical applications, where robustness and reproducibility are key priorities.
In this webinar we will look into how the Evosep One with high-throughput and sensitivity is a good fit when developing new drug applications or biologics license applications.
Find the latest publications from our
users and collaboration partners
What we do
Our mission at Evosep is to improve quality of life and patient care by radically innovating how protein based clinical diagnostics are performed.
Through collaborations with world-leading scientists we work to develop new technologies and solutions to make sample separation 10 times faster and 100 times more robust than todays’ alternatives.
We make it easy to get started
The Evosep One is a plug-and-play liquid chromatography platform built for standardization. It delivers a a high level of speed and robustness, while still maintaining the sensitivity needed when performing clinical proteomics.
The Evosep One removes sample handling steps and reduces injection cycle overheads with the use of Evotips as disposable trap columns.
Explore resarch from our users
Here you can find the latest publications from our users and collaboration partners and also dig into the full library of publications with Evosep One. Use the search function to explore more or get inspiration from the tags and categories.
It’s all in the tip
The Evotip speeds up sample loading, reduces carry-over and is a significant contribution to why proteomics has become so easy and routine.
It lets you load a very small amount of sample on the tip that, once immobilized, is extremely stable and stays right where it is. This makes it possible to store the proteome, even from a single cell on the tips, until you elute into the Evosep One.
You decide how fast you want to go
with The five standard methods
The five standard methods enable the Evosep One to cover a range of use cases from comprehensive proteome analysis with 30 samples analyzed per day to ultra-high throughput single-shot analysis with 300 samples analyzed per day.
News from Evosep
Dive in to the latest news from Evosep and read about user research, new applications and much more.
EasyM – A personalized MS-based assay to monitor multiple 2 myeloma disease assessment facilitated by the Evosep One
This publication by the Trudel group describes the development of a non-invasive MS-based assay, called EasyM, which is used to assess minimal residual disease, a measure of depth of remission to treatment, which has become an important parameter in assessing the disease burden in multiple myeloma.
A blood atlas of COVID-19 defines hallmarks of disease – High-throughput plasma proteomics on the Evosep One
This publication is a major collaboration led by the Knight group at University of Oxford describing the hallmarks of Covid-19 severity and specificity. It is an integrative multi-omics analysis, where the Evosep One was used for measuring 340 plasma proteomes providing excellent patient stratification.
Get inspired with published appplications
from our users
Evosep One offers a wide range of applications – from understanding the Covid-19 disease to the identification of proteins with short gradients.
Dive into the inspiring research from our users around the world and explore the possibilities of clinical proteomics with Evosep One.
Evosep webinars: Meet Evosep One users
Join us once a month when we zoom in on a new topic and invite Evosep One users and collaborators to share their work.
It is our hope and goal to make these events a popular platform where Evosep One users can share their research with the rest of the world.
More than 20 years in the industry
The story of Evosep goes way back. Many of our employees have a long history within the nanoLC and the proteomics community and have been with us long before Evosep was founded in 2016.
We base our design on years of experience with nano-UHPLC R&D and application support, critically rethinking the necessary system architectures for successful sample separation before mass spectrometric analysis.
Let’s get in touch
Don’t hesistate to reach out, we are always open to answering questions and form new collaborations. Fill out our contact form and we’ll do our very best to assist you.